drugset / Trial / NCT02331602
Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran
Phase 4
Unknown
200 enrolled
Yokohama City University Medical Center
Yokohama City University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the antiinflammatory effects of rivaroxaban compared with dabigatran in patients with atrial fibrillation.
Timeline
- Start
- 2013-07
- Primary completion
- 2015-10
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dabigatran | Unknown | 110 mg | — |
| Comparator | Dabigatran | Unknown | 150 mg | — |
| Comparator | Rivaroxaban | Other / unclassified | 10 mg | — |
| Comparator | Rivaroxaban | Other / unclassified | 15 mg | — |